Alder BioPharmaceuticals Reports First Quarter 2016 Financial and Operating Results

Go back to Alder BioPharmaceuticals Reports First Quarter 2016 Financial and Operating Results

Alder BioPharma (ALDR) Misses Q1 EPS by 4c

April 28, 2016 4:45 PM EDT

Alder BioPharma (NASDAQ: ALDR) reported Q1 EPS of ($0.76), $0.04 worse than the analyst estimate of ($0.72).

For earnings history and earnings-related data on Alder BioPharma (ALDR) click here.

... More